SCHEMBL6515699

SCHEMBL6515699

Cc1[nH]nc2c1c(=O)n(CCCNC(=O)c1cccc(Cl)c1)c1ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 3/20 0.55
MAPT P10636 1/20 0.49
AURKA O14965 1/20 0.47
KDR P35968 1/20 0.47
AURKB Q96GD4 1/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
BRD4 O60885 2/20 0.46
NAMPT P43490 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.42
CNR2 P34972 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
THRB P10828 1/20 0.42
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
PLK1 P53350 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6523103 0.90 CHEK1 (0.55) CHEK1MAPTAURKAKDRAURKB
SCHEMBL6519817 0.90 CHEK1 (0.50) CHEK1AURKAKDRAURKBBRD4
SCHEMBL6521705 0.85 AURKA (0.51) CHEK1MAPTAURKAKDRAURKB
SCHEMBL6517509 0.85 AURKA (0.48) CHEK1AURKAKDRAURKBMEN1
SCHEMBL6522359 0.85 CHEK1 (0.50) CHEK1AURKAKDRAURKBMEN1
SCHEMBL6514143 0.85 CHEK1 (0.57) CHEK1AURKAKDRAURKBMEN1
SCHEMBL6517752 0.85 AURKA (0.50) CHEK1MAPTAURKAKDRAURKB
SCHEMBL6513032 0.84 CHEK1 (0.53) CHEK1MAPTAURKAKDRAURKB
SCHEMBL6513140 0.84 AURKA (0.49) CHEK1MAPTAURKAKDRAURKB
SCHEMBL6513075 0.83 AURKA (0.48) CHEK1AURKAKDRAURKBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050245563-A1 Chk-1 inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245563-A1 Chk-1 inhibitors CHKA, CHKB, CHEK1 CHEK1 3/4885MAPT 3744/4885AURKA 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.